Correlation Between Suzhou Novoprotein and Kingsignal Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Kingsignal Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Kingsignal Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Kingsignal Technology Co, you can compare the effects of market volatilities on Suzhou Novoprotein and Kingsignal Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Kingsignal Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Kingsignal Technology.

Diversification Opportunities for Suzhou Novoprotein and Kingsignal Technology

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Suzhou and Kingsignal is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Kingsignal Technology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kingsignal Technology and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Kingsignal Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kingsignal Technology has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Kingsignal Technology go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Kingsignal Technology

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Kingsignal Technology. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 2.63 times less risky than Kingsignal Technology. The stock trades about -0.09 of its potential returns per unit of risk. The Kingsignal Technology Co is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  943.00  in Kingsignal Technology Co on October 6, 2024 and sell it today you would lose (27.00) from holding Kingsignal Technology Co or give up 2.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy97.73%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Kingsignal Technology Co

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Kingsignal Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kingsignal Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Kingsignal Technology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Suzhou Novoprotein and Kingsignal Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Kingsignal Technology

The main advantage of trading using opposite Suzhou Novoprotein and Kingsignal Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Kingsignal Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kingsignal Technology will offset losses from the drop in Kingsignal Technology's long position.
The idea behind Suzhou Novoprotein Scientific and Kingsignal Technology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Valuation
Check real value of public entities based on technical and fundamental data